Filter posts

The Challenges and Risks of Adopting Foreign Price Controls

The Trump Administration is moving forward with a plan to import foreign price controls into …

Executive Order on Agricultural Biotechnology Is an Important Step Forward

During his June 11th visit to Iowa, President Donald Trump pledged to boost the ethanol …

Greenwood: In Pharma Value Chain, PBMs Manage to Benefit

Writing for The Hill, BIO’s President and CEO Jim Greenwood offered praise to the Senate Finance …

Oncologist Warns of IPI’s Potentially Dangerous Implications

Writing for Morning Consult, Dr. Lucy Langer, a clinical oncologist with Compass Oncology in Portland, …

Policy Outlook—How Could the Trump Administration’s Drug Reimbursement Proposals Affect Medical ...

In his State of the Union address, President Trump called on Congress to “do more” …

Trump Administration Should Remain Steadfast in Pushing China Towards Structural Reforms

As part of the 90-day trade negotiations between the United States and China, today Chinese …

A Helpful Spotlight on the Need for More Health Care Transparency

This week, the Trump administration addressed a problem confronting a growing number of Americans: surprise …

Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innov...

In October of 2018, the Trump Administration outlined a proposal that would import foreign price …

The Administration’s Orwellian Defense of Importing Foreign Price Controls

The Trump administration is out with a new blog post defending its plan to adopt …

Think the Drug-Pricing debate addresses Patient Costs? Think again.

Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate …